Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Sci Rep ; 12(1): 3186, 2022 02 24.
Article in English | MEDLINE | ID: mdl-35210456

ABSTRACT

Sexual differentiation of the brain is influenced by testosterone and its metabolites during the perinatal period, when many aspects of brain development, including the maturation of GABAergic transmission, occur. Whether and how testosterone signaling during the perinatal period affects GABAergic transmission is unclear. Here, we analyzed GABAergic circuit functional markers in male, female, testosterone-treated female, and testosterone-insensitive male rats after the first postnatal week and in young adults. In the hippocampus, mRNA levels of proteins associated with GABA signaling were not significantly affected at postnatal day (P) 7 or P40. Conversely, membrane protein levels of KCC2, which are critical for determining inhibition strength, were significantly higher in females compared to males and testosterone-treated females at P7. Further, female and testosterone-insensitive male rats at P7 showed higher levels of the neurotrophin BDNF, which is a powerful regulator of neuronal function, including GABAergic transmission. Finally, spontaneous GABAergic currents in hippocampal CA1 pyramidal cells were more frequent in females and testosterone-insensitive males at P40. Overall, these results show that perinatal testosterone levels modulate GABAergic circuit function, suggesting a critical role of perinatal sex hormones in regulating network excitability in the adult hippocampus.


Subject(s)
GABAergic Neurons/metabolism , Hippocampus/metabolism , Neurons/metabolism , Pyramidal Cells/metabolism , Symporters/metabolism , Synaptic Transmission/drug effects , Testosterone/pharmacology , Androgen-Insensitivity Syndrome/genetics , Animals , Animals, Newborn/metabolism , Female , GABAergic Neurons/drug effects , Hippocampus/drug effects , Male , Mutation , Neurons/drug effects , Pyramidal Cells/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Androgen/metabolism , Sex Characteristics
2.
Nanomedicine ; 40: 102478, 2022 02.
Article in English | MEDLINE | ID: mdl-34743018

ABSTRACT

Precise detection of brain regions harboring heightened electrical activity plays a central role in the understanding and treatment of diseases such as epilepsy. Superparamagnetic iron oxide nanoparticles (SPIONs) react to magnetic fields by aggregating and represent interesting candidates as new sensors for neuronal magnetic activity. We hypothesized that SPIONs in aqueous solution close to active brain tissue would aggregate proportionally to neuronal activity. We tested this hypothesis using an in vitro model of rat brain slice with different levels of activity. Aggregation was assessed with dynamic light scattering (DLS) and magnetic resonance imaging (MRI). We found that increasing brain slice activity was associated with higher levels of aggregation as measured by DLS and MRI, suggesting that the magnetic fields from neuronal tissue could induce aggregation in nearby SPIONs in solution. MRI signal change induced by SPIONs aggregation could serve as a powerful new tool for detection of brain electrical activity.


Subject(s)
Magnetite Nanoparticles , Animals , Brain , Magnetic Iron Oxide Nanoparticles , Magnetic Resonance Imaging/methods , Neurons , Rats
3.
Can J Neurol Sci ; 49(4): 595-597, 2022 07.
Article in English | MEDLINE | ID: mdl-34183079

ABSTRACT

We present five cases of pediatric drug-resistant epilepsy (DRE) that failed management using high cannabidiol (CBD) doses, but had significant reduction in seizure frequency with reintroduction or increasing doses of tetrahydrocannabinol (THC). There is growing evidence supporting the use of whole-plant CBD-rich extracts (containing THC and other cannabinoids) in the treatment of pediatric DRE. Based on our experiences and reports in the literature, we propose that, in patients who fail management with an initial trial of high-dose CBD-focused therapy, there may be a role for add-on THC-focused formulations.


Subject(s)
Cannabidiol , Drug Resistant Epilepsy , Cannabidiol/therapeutic use , Cannabis , Child , Dronabinol/therapeutic use , Drug Resistant Epilepsy/drug therapy , Humans , Plant Extracts/therapeutic use , Seizures/drug therapy
4.
Neurobiol Dis ; 161: 105546, 2021 12.
Article in English | MEDLINE | ID: mdl-34742878

ABSTRACT

Febrile seizures (FS) are common, affecting 2-5% of children between the ages of 3 months and 6 years. Complex FS occur in 10% of patients with FS and are strongly associated with mesial temporal lobe epilepsy. Current research suggests that predisposing factors, such as genetic and anatomic abnormalities, may be necessary for complex FS to translate to mesial temporal lobe epilepsy. Sex hormones are known to influence seizure susceptibility and epileptogenesis, but whether sex-specific effects of early life stress play a role in epileptogenesis is unclear. Here, we investigate sex differences in the activity of the hypothalamic-pituitary-adrenal (HPA) axis following chronic stress and the underlying contributions of gonadal hormones to the susceptibility of hyperthermia-induced seizures (HS) in rat pups. Chronic stress consisted of daily injections of 40 mg/kg of corticosterone (CORT) subcutaneously from postnatal day (P) 1 to P9 in male and female rat pups followed by HS at P10. Body mass, plasma CORT levels, temperature threshold to HS, seizure characteristics, and electroencephalographic in vivo recordings were compared between CORT- and vehicle (VEH)-injected littermates during and after HS at P10. In juvenile rats (P18-P22), in vitro CA1 pyramidal cell recordings were recorded in males to investigate excitatory and inhibitory neuronal circuits. Results show that daily CORT injections increased basal plasma CORT levels before HS and significantly reduced weight gain and body temperature threshold of HS in both males and females. CORT also significantly lowered the generalized convulsions (GC) latency while increasing recovery time and the number of electrographic seizures (>10s), which had longer duration. Furthermore, sex-specific differences were found in response to chronic CORT injections. Compared to females, male pups had increased basal plasma CORT levels after HS, longer recovery time and a higher number of electrographic seizures (>10s), which also had longer duration. Sex-specific differences were also found at baseline conditions with lower latency to generalized convulsions and longer duration of electrographic seizures in males but not in females. In juvenile male rats, the amplitude of evoked excitatory postsynaptic potentials, as well as the amplitude of inhibitory postsynaptic currents, were significantly greater in CORT rats when compared to VEH littermates. These findings not only validate CORT injections as a stress model, but also show a sex difference in baseline conditions as well as a response to chronic CORT and an impact on seizure susceptibility, supporting a potential link between sustained early-life stress and complex FS. Overall, these effects also indicate a putatively less severe phenotype in female than male pups. Ultimately, studies investigating the biological underpinnings of sex differences as a determining factor in mental and neurologic problems are necessary to develop better diagnostic, preventative, and therapeutic approaches for all patients regardless of their sex.


Subject(s)
Hyperthermia, Induced , Seizures, Febrile , Animals , Corticosterone , Female , Humans , Hyperthermia, Induced/adverse effects , Hypothalamo-Hypophyseal System , Male , Rats , Seizures/etiology , Seizures, Febrile/etiology , Sex Characteristics
5.
Epilepsy Res ; 172: 106585, 2021 05.
Article in English | MEDLINE | ID: mdl-33636503

ABSTRACT

BACKGROUND: Precise detection of zones of increased brain activity is a crucial aspect in the delineation of the cortical region responsible for epilepsy (epileptic focus). When possible, removal of this area can lead to improved control of epilepsy or even its cure. This study explores a new method of detection of electrical brain activity based on the surgical implantation of iron oxide superparamagnetic nanoparticles (SPIONs). By their magnetic nature, SPIONs tend to aggregate in the presence of magnetic fields. This study aims to demonstrate if brain's magnetic fields could change the aggregation status of SPIONs in a rat model. METHODS: Plastic containers (capsules) containing SPIONs in aqueous suspension were implanted over the cortex of either rats rendered epileptic or naive rats (sham). A model of focal epilepsy using cortical penicillin injection was used for the epileptic rats. Capsules not implanted in rats served as control. Using magnetic resonance imaging (MRI), the aggregation status of SPIONs contained in the capsules was assessed via measurement of the T2 relaxivity time of the solutions. RESULTS: Eight Rats were used for the experiments, with 4 rats in each group (epileptic and sham). One Rat in the sham group died immediately after surgery and 3 rats failed to demonstrate the expected behavior after intervention (2 rats in epileptic group with limited observable seizures and 1 rat in the sham group having repeated seizures). T2 of the control capsules were significantly lower than those implanted in rats (146 ms vs 7.6 ms, p < 0.001), suggesting a higher degree of SPIONs aggregation in the implanted capsules. No significant difference in T2 could be demonstrated between epileptic and sham rats. CONCLUSIONS: SPIONs implanted over the cortex of active brain showed an increased aggregation status, confirming their potential as a new marker for brain activity. One of the main advantages of SPIONs is that their aggregation status can be measured at a distance with MRI, taking advantage of its high spatial resolution and imaging capacities. The current model was suboptimal to confirm if epileptic activity can be differentiated from normal brain activity using SPIONs.


Subject(s)
Brain , Magnetite Nanoparticles , Animals , Brain/diagnostic imaging , Capsules , Feasibility Studies , Rats , Seizures
6.
J Clin Invest ; 128(5): 2000-2009, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29629902

ABSTRACT

Rasmussen's encephalitis (RE) is a chronic inflammatory brain disorder that causes frequent seizures and unilateral hemispheric atrophy with progressive neurological deficits. Hemispherectomy remains the only treatment that leads to seizure freedom for this refractory epileptic syndrome. The absence of an animal model of disease has been a major obstacle hampering the development of effective therapies. Here, we describe an experimental mouse model that shares several clinical and pathological features with the human disease. Immunodeficient mice injected with peripheral blood mononuclear cells from RE patients and monitored by video electroencephalography developed severe seizures of cortical origin and showed intense astrogliosis and accumulation of human IFN-γ- and granzyme B-expressing T lymphocytes in the brain compared with mice injected with immune cells from control subjects. We also provide evidence for the efficacy of α4 integrin blockade, an approved therapy for the treatment of multiple sclerosis and Crohn's disease, in reducing inflammatory markers associated with RE in the CNS. This model holds promise as a valuable tool for understanding the pathology of RE and for developing patient-tailored experimental therapeutics.


Subject(s)
Brain/immunology , Encephalitis/immunology , Inflammation/immunology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/transplantation , Seizures/immunology , Adolescent , Adult , Animals , Brain/diagnostic imaging , Brain/physiopathology , Child , Disease Models, Animal , Electroencephalography , Encephalitis/diagnostic imaging , Encephalitis/physiopathology , Female , Heterografts , Humans , Inflammation/diagnostic imaging , Inflammation/physiopathology , Male , Mice , Middle Aged , Seizures/diagnostic imaging , Seizures/physiopathology
7.
Epilepsy Behav ; 79: 117-125, 2018 02.
Article in English | MEDLINE | ID: mdl-29287214

ABSTRACT

Levetiracetam (LEV), and its newer selective analog brivaracetam (BRV), are two seizure medications that share an innovative mechanism of action targeting the Synaptic Vesicle Protein 2A (SV2A), altering neurotransmitter release and decreasing seizure frequency. Behavioral changes are the most significant adverse effects reported by patients taking LEV. We hypothesize that BRV, the more potent SV2A analog, could exert less behavioral side effects, as it requires lower doses than LEV. Using Kainic Acid (KA)-treated and control rats, we measured adverse behavioral effect profiles of LEV, BRV, or Saline, on social and nonsocial behaviors. Our data indicate that both tested drugs had no effect on locomotion, anxiety levels, fear learning, depression-like behavior, and memory retention in rats. However, when considering social interactions, we first confirmed the epilepsy-induced strong increase in aggressive behaviors and specific hippocampal neuronal loss. We furthermore observed, in Sham rats, that LEV-treated animals were 2 times faster to attack at first encounter, had 5 times more aggressive behaviors, and had significantly less social behaviors than control rats. In all circumstances, BRV rats behaved like Saline rats, suggesting that BRV treatment in rats leads to significantly less aggressive behaviors than LEV treatment at the doses used, while there are limited differential effects between these two drugs on other types of behaviors. Since increased aggressiveness has been reported in patients well controlled on LEV, this study indicates based on our findings, that BRV could represent an effective alternative to LEV to limit aggressiveness problems due to this antiepileptic drug (AED) therapy.


Subject(s)
Anticonvulsants/adverse effects , Epilepsy/drug therapy , Kainic Acid/pharmacology , Levetiracetam/adverse effects , Pyrrolidinones/adverse effects , Seizures/drug therapy , Synaptic Transmission/drug effects , Animals , Anticonvulsants/therapeutic use , Drug-Related Side Effects and Adverse Reactions , Epilepsy/chemically induced , Hippocampus/drug effects , Humans , Levetiracetam/therapeutic use , Male , Pyrrolidinones/therapeutic use , Rats , Seizures/epidemiology
8.
Neurobiol Dis ; 91: 10-20, 2016 07.
Article in English | MEDLINE | ID: mdl-26875662

ABSTRACT

Atypical febrile seizures are considered a risk factor for epilepsy onset and cognitive impairments later in life. Patients with temporal lobe epilepsy and a history of atypical febrile seizures often carry a cortical malformation. This association has led to the hypothesis that the presence of a cortical dysplasia exacerbates febrile seizures in infancy, in turn increasing the risk for neurological sequelae. The mechanisms linking these events are currently poorly understood. Potassium-chloride cotransporter KCC2 affects several aspects of neuronal circuit development and function, by modulating GABAergic transmission and excitatory synapse formation. Recent data suggest that KCC2 downregulation contributes to seizure generation in the epileptic adult brain, but its role in the developing brain is still controversial. In a rodent model of atypical febrile seizures, combining a cortical dysplasia and hyperthermia-induced seizures (LHS rats), we found a premature and sustained increase in KCC2 protein levels, accompanied by a negative shift of the reversal potential of GABA. In parallel, we observed a significant reduction in dendritic spine size and mEPSC amplitude in CA1 pyramidal neurons, accompanied by spatial memory deficits. To investigate whether KCC2 premature overexpression plays a role in seizure susceptibility and synaptic alterations, we reduced KCC2 expression selectively in hippocampal pyramidal neurons by in utero electroporation of shRNA. Remarkably, KCC2 shRNA-electroporated LHS rats show reduced hyperthermia-induced seizure susceptibility, while dendritic spine size deficits were rescued. Our findings demonstrate that KCC2 overexpression in a compromised developing brain increases febrile seizure susceptibility and contribute to dendritic spine alterations.


Subject(s)
Brain/metabolism , Dendritic Spines/metabolism , Dendritic Spines/pathology , Seizures, Febrile/pathology , Symporters/metabolism , Animals , Animals, Newborn , Brain/growth & development , Disease Susceptibility/metabolism , Epilepsy/physiopathology , Memory Disorders/metabolism , Neurogenesis/physiology , Pyramidal Cells/metabolism , Rats, Sprague-Dawley , Seizures, Febrile/metabolism , Seizures, Febrile/physiopathology , K Cl- Cotransporters
9.
Annu Int Conf IEEE Eng Med Biol Soc ; 2016: 4216-4219, 2016 Aug.
Article in English | MEDLINE | ID: mdl-28269213

ABSTRACT

The study of cerebral magnetic activity is very promising for the understanding and care of diseases involving impaired cerebral activity such as epilepsy. One of the main hurdle in the recording of cerebral magnetic activity is that the intensity of cerebral magnetic fields is very weak. In this regard, we explore another potential way to appreciate the magnetic cerebral activity using superparamagnetic nanoparticles. These particles react to magnetic fields and can aggregate under their influence. Being superparamagnetic, they are also visible on magnetic resonance imaging (MRI). Superparamagnetic nanoparticles distributed in cerebral tissue could aggregate under the influence of local magnetic fields, with this aggregation being visible using MRI. In order to explore the feasibility of this new concept, we observed the behaviour of nanoparticles brought in proximity of living rat's brain slices of different levels of activity. A statistically significant aggregation of nanoparticles that is proportional to the rat's brain activity was observed in the study of 9 rats. These results favour the statement that brain electrical magnetic fields are sufficient to induce an aggregation of superparamagnetic nanoparticles in their vicinity. These results serve as a first "stepping stone" for the basis of a new method to appreciate brain magnetic activity using aggregation of nanoparticles as a marker of increased brain activity.


Subject(s)
Brain/diagnostic imaging , Magnetite Nanoparticles/chemistry , Animals , Brain/metabolism , In Vitro Techniques , Magnetic Resonance Imaging , Microscopy, Fluorescence , Models, Animal , Rats , Rats, Sprague-Dawley , Receptors, GABA/metabolism
10.
Circ Arrhythm Electrophysiol ; 8(4): 912-20, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26067667

ABSTRACT

BACKGROUND: Arrhythmias associated with QT prolongation on the ECG often lead to sudden unexpected death in epilepsy. The mechanism causing a prolongation of the QT interval during epilepsy remains unknown. Based on observations showing an upregulation of neuronal sodium channels in the brain during epilepsy, we tested the hypothesis that a similar phenomenon occurs in the heart and contributes to QT prolongation by altering cardiac sodium current properties (INa). METHODS AND RESULTS: We used the patch clamp technique to assess the effects of epilepsy on the cardiac action potential and INa in rat ventricular myocytes. Consistent with QT prolongation, epileptic rats had longer ventricular action potential durations attributable to a sustained component of INa (INaL). The increase in INaL was because of a larger contribution of neuronal Na channels characterized by their high sensitivity to tetrodotoxin. As in the brain, epilepsy was associated with an enhanced expression of the neuronal isoform NaV1.1 in cardiomyocyte. Epilepsy was also associated with a lower INa activation threshold resulting in increased cell excitability. CONCLUSIONS: This is the first study correlating increased expression of neuronal sodium channels within the heart to epilepsy-related cardiac arrhythmias. This represents a new paradigm in our understanding of cardiac complications related to epilepsy.


Subject(s)
Action Potentials/physiology , Arrhythmias, Cardiac/genetics , DNA/genetics , Death, Sudden/etiology , Epilepsy/metabolism , Gene Expression Regulation , Myocytes, Cardiac/metabolism , NAV1.5 Voltage-Gated Sodium Channel/genetics , Animals , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/metabolism , Blotting, Western , Epilepsy/complications , Epilepsy/mortality , Male , NAV1.5 Voltage-Gated Sodium Channel/biosynthesis , Patch-Clamp Techniques , Rats , Real-Time Polymerase Chain Reaction
11.
Epilepsy Res Treat ; 2012: 342928, 2012.
Article in English | MEDLINE | ID: mdl-22957226

ABSTRACT

Febrile seizures occurring in the neonatal period, especially when prolonged, are thought to be involved in the later development of mesial temporal lobe epilepsy (mTLE) in children. The presence of an often undetected, underlying cortical malformation has also been reported to be implicated in the epileptogenesis process following febrile seizures. This paper highlights some of the various animal models of febrile seizures and of cortical malformation and portrays a two-hit model that efficiently mimics these two insults and leads to spontaneous recurrent seizures in adult rats. Potential mechanisms are further proposed to explain how these two insults may each, or together, contribute to network hyperexcitability and epileptogenesis. Finally the clinical relevance of the two-hit model is briefly discussed in light of a therapeutic and preventive approach to mTLE.

12.
PLoS One ; 7(8): e42622, 2012.
Article in English | MEDLINE | ID: mdl-22880055

ABSTRACT

During development, the risk of developing mesial temporal lobe epilepsy (MTLE) increases when the developing brain is exposed to more than one insult in early life. Early life insults include abnormalities of cortical development, hypoxic-ischemic injury and prolonged febrile seizures. To study epileptogenesis, we have developed a two-hit model of MTLE characterized by two early-life insults: a freeze lesion-induced cortical malformation at post-natal day 1 (P1), and a prolonged hyperthermic seizure (HS) at P10. As early life stressors lead to sexual dimorphism in both acute response and long-term outcome, we hypothesized that our model could lead to gender-based differences in acute stress response and long-term risk of developing MTLE. Male and female pups underwent a freeze-lesion induced cortical microgyrus at P1 and were exposed to HS at P10. Animals were monitored by video-EEG from P90 to P120. Pre and post-procedure plasma corticosterone levels were used to measure stress response at P1 and P10. To confirm the role of sex steroids, androgenized female pups received daily testosterone injections to the mother pre-natally and post-natally for nine days while undergoing both insults. We demonstrated that after both insults females did not develop MTLE while all males did. This correlated with a rise in corticosterone levels at P1 following the lesion in males only. Interestingly, all androgenized females showed a similar rise in corticosterone at P1, and also developed MTLE. Moreover, we found that the cortical lesion significantly decreased the latency to generalized convulsion during hyperthermia at P10 in both genders. The cortical dysplasia volumes at adulthood were also similar between male and female individuals. Our data demonstrate sexual dimorphism in long-term vulnerability to develop epilepsy in the lesion + hyperthermia animal model of MTLE and suggest that the response to early-life stress at P1 contributes significantly to epileptogenesis in a gender-specific manner.


Subject(s)
Disease Susceptibility/pathology , Epilepsy/pathology , Sex Characteristics , Stress, Psychological/pathology , Androgens/metabolism , Animals , Animals, Newborn , Behavior, Animal , Benzoxazines , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Corticosterone/blood , Electroencephalography , Epilepsy/physiopathology , Female , Hyperthermia, Induced , Male , Organ Size , Oxazines , Rats , Rats, Sprague-Dawley , Video Recording
13.
Epilepsia ; 51(8): 1607-18, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20698876

ABSTRACT

PURPOSE: Specific inhibitory interneurons in area CA1 of the hippocampus, notably those located in stratum oriens-alveus (O/A-INs), are selectively vulnerable in patients and animal models of temporal lobe epilepsy (TLE). The excitotoxic mechanisms underlying the selective vulnerability of interneurons have not been identified but could involve group I metabotropic glutamate receptor subtypes (mGluR1/5), which have generally proconvulsive actions and activate prominent cationic currents and calcium responses specifically in O/A-INs. METHODS: In this study, we examine the role of mGluR1/5 in interneurons during epileptiform activity using whole-cell recordings from CA1 O/A-INs and selective antagonists of mGluR1α (LY367385) and mGluR5 (MPEP) in a disinhibited rat hippocampal slice model of epileptiform activity. RESULTS: Our data indicate more prominent epileptiform burst discharges and paroxysmal depolarizations (PDs) in O/A-INs than in interneurons located at the border of strata radiatum and lacunosum/moleculare (R/LM-INs). In addition, mGluR1 and mGluR5 significantly contributed to epileptiform responses in O/A-INs but not in R/LM-INs. Epileptiform burst discharges in O/A-INs were partly dependent on mGluR5. PDs and associated postsynaptic currents were dependent on both mGluR1α and mGluR5. These receptors contributed differently to postsynaptic currents underlying PDs, with mGluR5 contributing to the fast and slow components and mGluR1α to the slow component. DISCUSSION: These findings support interneuron subtype-specific activation and differential contributions of mGluR1α and mGluR5 to epileptiform activity in O/A-INs, which could be important for their selective vulnerability in TLE.


Subject(s)
Action Potentials/physiology , Hippocampus/cytology , Interneurons/classification , Interneurons/physiology , Receptors, Metabotropic Glutamate/metabolism , Action Potentials/drug effects , Animals , Animals, Newborn , Bicuculline/pharmacology , Drug Interactions , Electric Stimulation/methods , Excitatory Amino Acid Antagonists/pharmacology , GABA Antagonists/pharmacology , In Vitro Techniques , Male , Patch-Clamp Techniques/methods , Rats , Rats, Sprague-Dawley , Receptor, Metabotropic Glutamate 5 , Receptors, Metabotropic Glutamate/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...